PEGylation is effective in reducing immunogenicity, immunotoxicity, and hepatotoxicity of α-momorcharinin vivo

PEGylation of alpha-momorcharin: synthesis and characterization of novel anti-tumor conjugates with therapeutic potential

(2010) Xiaoxiao Bian et al.   BIOTECHNOLOGY LETTERS

Safety and toxicological evaluation of AlgaeCal®(AC), a novel plant-based calcium supplement

(2010) Palma Ann Marone et al.   TOXICOLOGY MECHANISMS AND METHODS

Safety and toxicological evaluation of a novel chromium(III) dinicocysteinate complex

(2010) Nair Sreejayan et al.   TOXICOLOGY MECHANISMS AND METHODS

Anti-tumor activity and immunological modification of ribosome-inactivating protein (RIP) from Momordica charantia by covalent attachment of polyethylene glycol

(2009) M. Li et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

PEG conjugates in clinical development or use as anticancer agents: An overview

(2009) Gianfranco Pasut et al.   ADVANCED DRUG DELIVERY REVIEWS

Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC)

(2009) Sam-Mui Tsui et al.   Cancer Cell International

PEGylated lactoferrin enhanced its hepatoprotective effects on acute liver injury induced by carbon tetrachloride in rats

(2009) Akihiko Sugiyama et al.   FOOD AND CHEMICAL TOXICOLOGY

Advances in PEGylation of important biotech molecules: delivery aspects

(2008) Sinéad M Ryan et al.   Expert Opinion on Drug Delivery

PEGylation of brain-derived neurotrophic factor for preserved biological activity and enhanced spinal cord distribution

(2008) Ryan G. Soderquist et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A